Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2608

LikeLikedUnlike

Episodes 286-300 of 745

Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  Peer
- Rishi Wadhera, MD, MPP, Mphil
  Peer
1.00 program credits
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  Peer
- Rishi Wadhera, MD, MPP, Mphil
  Peer
1.00 program credits
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®
Bridging ASCVD Care Between Academic and Rural Settings
- Rishi Wadhera, MD, MPP, Mphil
  Peer
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  Peer
1.00 program credits
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
- Darren Brenner, MD
  Peer
0.25 credits
Topline Results of the CONFIDENCE Trial
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)
Topline Results of the CONFIDENCE Trial
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
  Peer
Albuminuria Change and Finerenone's Effect on CV Outcomes
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)
Albuminuria Change and Finerenone's Effect on CV Outcomes
- Finnian R. McCausland, MD
  Peer
advertisement
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
CME/CE
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
- Cynthia J. Bither, ACNP-BC, MSN
  Peer
- Andrea Wallace, MSN, FNP-C, HF-Cert
  Peer
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CE
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
- prof. Hiddo Heerspink
  Peer
- Jennifer B. Green, MD
  Peer
0.25 credits
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CE
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
0.25 credits
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
CME/CE
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
- Theresa W. Gillespie, PhD, MA, RN, FAAN
  Peer
- Kristi Orbaugh, MSN, RNP, AOCN
  Peer
- Kimberly Podsada, MSN, NP-C
  Peer
1.50 credits
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
- Justis P. Ehlers, MD, FASRS
  Peer
- Roger A. Goldberg, MD, MBA
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 credits 10 episodes
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
- Robert D. Suh, MD
  Peer
- Lea Azour, MD
  Peer
- Ashwin Basavaraj, MD
  Peer
1.00 credits
advertisement
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®
Second-Generation Biomarkers for Treatment Outcomes
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Macular Leakage: Indicator of Vascular Stability
MinuteCE®
Macular Leakage: Indicator of Vascular Stability
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended